Elucidation of Mechanism for Ligand Efficacy at Leukotriene B4Receptor 2 (BLT2)

Minsup Kim, Jun Dong Wei, Dipesh S. Harmalkar, Ja Il Goo, Kyeong Lee, Yongseok Choi, Jae-Hong Kim, Art E. Cho

Research output: Contribution to journalArticle

Abstract

G protein-coupled receptors (GPCRs) have always been important drug targets in the pharmaceutical industry. One major question for the current GPCR drug discovery is how drugs have distinct efficacies at the same GPCR target. Related to this question, we studied how different ligands can have disparate efficacies at Leukotriene B4 receptor (BLT2). By using molecular modeling studies, we predicted that Tyr2716.51 located at TM6 of BLT2 performs as a key trigger for its activation and verified the prediction by site-directed mutagenesis, chemotactic motility studies, which included a chemical derivative of agonist CAY10583. We further identified Asn2756.55 located at TM6 as a weak activation trigger in BLT2 and performed double mutation studies to confirm our computational results. Our results provide strong evidence for the exact mechanism of ligand efficacy at BLT2.

Original languageEnglish
Pages (from-to)1529-1534
Number of pages6
JournalACS Medicinal Chemistry Letters
Volume11
Issue number8
DOIs
Publication statusPublished - 2020 Aug 13

Keywords

  • chemical study
  • Leukotriene Breceptor 2
  • ligand efficacy
  • molecular modeling
  • mutagenesis study

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Elucidation of Mechanism for Ligand Efficacy at Leukotriene B<sub>4</sub>Receptor 2 (BLT2)'. Together they form a unique fingerprint.

Cite this